Skip to Content
Merck
  • Bioreduction of α,β-unsaturated ketones and aldehydes by non-conventional yeast (NCY) whole-cells.

Bioreduction of α,β-unsaturated ketones and aldehydes by non-conventional yeast (NCY) whole-cells.

Bioresource technology (2011-01-15)
Marta Goretti, Chiara Ponzoni, Elisa Caselli, Elisabetta Marchegiani, Maria Rita Cramarossa, Benedetta Turchetti, Luca Forti, Pietro Buzzini
ABSTRACT

The bioreduction of α,β-unsaturated ketones (ketoisophorone, 2-methyl- and 3-methyl-cyclopentenone) and aldehydes [(S)-(-)-perillaldehyde and α-methyl-cinnamaldehyde] by 23 "non-conventional" yeasts (NCYs) belonging to 21 species of the genera Candida, Cryptococcus, Debaryomyces, Hanseniaspora, Kazachstania, Kluyveromyces, Lindnera, Nakaseomyces, Vanderwaltozyma, and Wickerhamomyces was reported. The results highlight the potential of NCYs as whole-cell biocatalysts for selective biotransformation of electron-poor alkenes. A few NCYs exhibited extremely high (>90%) or even total ketoisophorone and 2-methyl-cyclopentenone bioconversion yields via asymmetric reduction of the conjugated CC bond catalyzed by enoate reductases. Catalytic efficiency declined after switching from ketones to aldehydes. High chemoselectivity due to low competing carbonyl reductases was also sometimes observed.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-Oxoisophorone, ≥98%, FG
Sigma-Aldrich
2,6,6-Trimethyl-2-cyclohexene-1,4-dione, 98%
Sigma-Aldrich
Cyclopentanone, ≥99%, FG
Sigma-Aldrich
Cyclopentanone, ReagentPlus®, ≥99%
Supelco
Cyclopentanone, analytical standard